Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Joachim P. Schmitt(Howard Hughes Medical Institute), Christine E. Seidman(Brigham and Women's Hospital), Ulrike Mende(Brown University), Ferhaan Ahmad(University of Iowa), David H. MacLennan(University of Toronto), Guo Hua Li(Howard Hughes Medical Institute), Evangelia G. Kranias(Howard Hughes Medical Institute), Mitsuhiro Kamisago(Brigham and Women's Hospital), Michio Asahi(Osaka University of Pharmaceutical Sciences), J G Seidman(Harvard University)
Cited by 628
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k